Evaxion Biotech AS (EVAX)
3.95
+0.06
(+1.54%)
USD |
NASDAQ |
May 03, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech 1 Year Total Returns (Daily): -69.14% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -69.14% |
May 02, 2024 | -69.84% |
May 01, 2024 | -69.21% |
April 30, 2024 | -66.90% |
April 29, 2024 | -65.95% |
April 26, 2024 | -67.34% |
April 25, 2024 | -68.55% |
April 24, 2024 | -70.50% |
April 23, 2024 | -72.03% |
April 22, 2024 | -71.69% |
April 19, 2024 | -70.28% |
April 18, 2024 | -72.77% |
April 17, 2024 | -76.38% |
April 16, 2024 | -74.10% |
April 15, 2024 | -73.72% |
April 12, 2024 | -63.39% |
April 11, 2024 | -66.75% |
April 10, 2024 | -66.19% |
April 09, 2024 | -65.57% |
April 08, 2024 | -64.43% |
April 05, 2024 | -68.46% |
April 04, 2024 | -69.07% |
April 03, 2024 | -68.42% |
April 02, 2024 | -65.66% |
April 01, 2024 | -71.42% |
Date | Value |
---|---|
March 28, 2024 | -69.81% |
March 27, 2024 | -75.21% |
March 26, 2024 | -74.76% |
March 25, 2024 | -75.00% |
March 22, 2024 | -75.98% |
March 21, 2024 | -70.67% |
March 20, 2024 | -70.58% |
March 19, 2024 | -70.19% |
March 18, 2024 | -70.10% |
March 15, 2024 | -72.31% |
March 14, 2024 | -73.18% |
March 13, 2024 | -71.94% |
March 12, 2024 | -71.24% |
March 11, 2024 | -70.29% |
March 08, 2024 | -72.32% |
March 07, 2024 | -75.08% |
March 06, 2024 | -76.23% |
March 05, 2024 | -76.95% |
March 04, 2024 | -75.65% |
March 01, 2024 | -76.86% |
February 29, 2024 | -76.62% |
February 28, 2024 | -76.23% |
February 27, 2024 | -76.32% |
February 26, 2024 | -75.42% |
February 23, 2024 | -75.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.84%
Minimum
Nov 04 2022
-4.92%
Maximum
May 19 2023
-59.38%
Average
-62.33%
Median
Aug 30 2022
1 Year Total Returns (Daily) Benchmarks
DBV Technologies SA | -57.25% |
Ascendis Pharma A/S | 49.85% |
Cellectis SA | 60.75% |
Adaptimmune Therapeutics PLC | -15.00% |
Akari Therapeutics PLC | -62.22% |